FFM
PFE icon

Fullerton Fund Management’s Pfizer PFE Stock Holding History

Fullerton Fund Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,042
Closed -$325K – 146
2025
Q4 		$325K Buy
+13,042
New +$329K 0.01% 98
2024
Q2 		– Sell
-15,226
Closed -$423K – 170
2024
Q1 		$423K Buy
+15,226
New +$422K 0.02% 88

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Fullerton Fund Management's PFE Position: Q1 2026 in Review

Fullerton Fund Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 13,042 shares — an estimated $325K sold.

Fullerton Fund Management first reported a position in PFE in Q1 2024 and held it in 2 quarters. The position peaked at $423K in Q1 2024. 2,963 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Fullerton Fund Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Fullerton Fund Management sold 13,042 Pfizer shares in Q1 2026, an estimated $325K.
  • Fullerton Fund Management first reported a position in Pfizer in Q1 2024 and held it in 2 quarters.
  • Fullerton Fund Management's Pfizer position peaked at $423K in Q1 2024.
  • 2,963 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Fullerton Fund Management's 13F filing for Q1 2026, filed 15 May 2026.